Drug Profile
Levothyroxine sodium - Fresenius Kabi
Latest Information Update: 01 Jan 2022
Price :
$50
*
At a glance
- Originator APP Pharmaceuticals
- Class Aromatic amino acids; Small molecules; Thyroid hormones
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypothyroidism
Most Recent Events
- 22 Jul 2015 The US FDA approved label for levothyroxine sodium for injection carries a black box warning